Skip to main content
Clinical Trials/NCT00345280
NCT00345280
Unknown
Not Applicable

Chosen Parameters of the Immune Response in the Origin of Ocular Changes in Patients With Cystic Fibrosis

University of Bialystok1 site in 1 country26 target enrollmentAugust 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Eye Manifestations
Sponsor
University of Bialystok
Enrollment
26
Locations
1
Last Updated
17 years ago

Overview

Brief Summary

Cystic fibrosis(CF) is an inherited disease affecting children, adolescents and young adults with dysfunction of secretory glands.It is caused by mutations in the protein-coding gene which function as the cystic fibrosis transmembrane regulator (CFTR), responsible for the secretion of chloride ions in epithelial cells, adenocytes, sweat gland cells, pancreatic ducts,alimentary and respiratory tracts and eye. Assessment of the relationship between the inflammatory processes and apoptosis in the eye in the course of cystic fibrosis will allow determination of immunological exponents which may facilitate diagnosis.

Detailed Description

The aim: To assess the role of chosen parameters of immunological response in the induction of ocular changes in cystic fibrosis patients, particularly chosen chemokine concentrations in the tear fluid and analysis of chosen apoptotic markers expression on conjunctival epithelial cells.

Registry
clinicaltrials.gov
Start Date
August 2006
End Date
September 2008
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Bialystok

Eligibility Criteria

Inclusion Criteria

  • male and female patients aged 3-25 with clinically definite diagnosis of cystic fibrosis
  • all patients must give written consent for participation in the study at screening

Exclusion Criteria

  • patients with a history of chronic disease of the immune system
  • patients with the history of systemic diseases
  • patients with the history chronic ocular diseases
  • patients who have been treated with corticosteroids in the past 3 months prior to the screening visit

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials